It is highly expected that the development of new types of high-performance multifunctional AID inhibitors shown in this study would provide efficient SDT to cancer through inhibiting AID and could be widely used in treating AID-positive neoplasm and tumors with advantages of cost-effectiveness, convenience, and noninvasiveness. Here, AICDA is linked to neoplasm.